节点文献

FS23 binds to the N-terminal domain of human Hsp90:A novel small inhibitor for Hsp90

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李健; 石峰; 陈丹琦; 曹慧玲; 熊兵; 沈竞康; 何建华;

【Author】 LI Jian;SHI Feng;CHEN Dan-Qi;CAO Hui-Ling;XIONG Bing;SHEN Jing-Kang;HE Jian-Hua;Shanxi Key Laboratory of Ischemic Cardiovascular Disease; Institute of Basic & Translational Medicine, Xi’an Medical University;Shanghai Institute of Applied Physics, Chinese Academy of Sciences;Department of Medicinal Chemistry, State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica, Chinese Academy of Sciences;

【机构】 Shanxi Key Laboratory of Ischemic Cardiovascular Disease; Institute of Basic & Translational Medicine, Xi’an Medical University; Shanghai Institute of Applied Physics, Chinese Academy of Sciences; Department of Medicinal Chemistry, State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica, Chinese Academy of Sciences;

【摘要】 The N-terminal domain of heat shock protein 90(Hsp90~N) is responsible for the catalytic activity of Hsp90.The reported inhibitors of Hsp90 bind to this domain and would inhibit tumor growth and progression. Here,we synthesized FS23, a small molecule inhibitor of hsp90 and collected X-ray diffraction data of the complex crystal of Hsp90-FS23. High resolution X-ray crystallography shows that FS23 interacted with Hsp90 Nat the nucleotide binding cleft, and this suggests that FS23 may complete with nucleotides to bind to Hsp90~N. The crystal structure and the interaction between Hsp90 Nand FS23 suggest a rational basis for the design of novel antitumor drugs.

【Abstract】 The N-terminal domain of heat shock protein 90(Hsp90~N) is responsible for the catalytic activity of Hsp90.The reported inhibitors of Hsp90 bind to this domain and would inhibit tumor growth and progression. Here,we synthesized FS23, a small molecule inhibitor of hsp90 and collected X-ray diffraction data of the complex crystal of Hsp90-FS23. High resolution X-ray crystallography shows that FS23 interacted with Hsp90 Nat the nucleotide binding cleft, and this suggests that FS23 may complete with nucleotides to bind to Hsp90~N. The crystal structure and the interaction between Hsp90 Nand FS23 suggest a rational basis for the design of novel antitumor drugs.

【基金】 Supported by National Natural Science Foundation of China(No.81402850);the Natural Science Basic Research Plan in Shaanxi Province of China(No.2015JM3114);the Introduced talents Foundation of Xi’an Medical University(No.2015 RCYJ01);the Doctorate Foundation of Xi’an Medical University(No.2015 DOC23)
  • 【文献出处】 Nuclear Science and Techniques ,核技术(英文版) , 编辑部邮箱 ,2015年06期
  • 【分类号】R915
  • 【被引频次】2
  • 【下载频次】58
节点文献中: 

本文链接的文献网络图示:

本文的引文网络